Regeneron Statistics, Revenue Totals and Facts (2021)



Here are a few of the most interesting Regeneron statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.


Regeneron Facts

  • Website: Official Website
  • Year Founded: 1988
  • Headquarters: Eastview, NY
  • Founder(s): Leonard Schleifer, Eric Manvers Shooter
  • Current Chief Executive: Leonard Schleifer

What is Regeneron?

Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases. (source)

Regeneron Employee Count

Regeneron number of employees:

6,500

Last updated 1/1/18


Regeneron Revenue Totals

Regeneron annual revenue:


Regeneron annual net income:


Get the Full Industry Report

dmr industry report company statistics factsThis full report is available in an annual industry report. Some of the data in industry reports include:

  • Company Quick Facts
  • Employee Counts
  • Income and Revenue Totals
  • Etc.- all in one place

I try to go through each and every stat regularly and update as much as possible, but we all know that some stats are easier to track down than others. As always, every stat is linked to its original source and has the source date listed.

To get your copy of the report, click on the button below to purchase it.

Report 1:  Biopharma Industry Report ( Abbott, Abbvie, Allergan, Amgen, Astellas, AstraZeneca, Bayer, Biogen, Bristol-Myers Squibb, Eli Lilly, Gilead, GlaxoSmithKline, Illumina, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, Stryker, Takeda, Vertex and Zoetis).


 

Please note that some of these numbers are easier to find than others. A few of these Regeneron stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.